IRCT20090117001556N139尚未招募2 期
aproxen as an adjuvant therapy for the treatment of obsessive-compulsive disorder (OCD): A randomized double blind and placebo controlled clinical trial
适应症
试验速览
- 阶段
- 2 期
- 状态
- 尚未招募
- 入组人数
- 50
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 years 至 60 years（—）
- 性别
- All
入选标准
- •Age between 18 to 60 years old
- •Diagnosis of OCD based on DSM-5
- •Score of >21 in Yale–Brown obsessive-compulsive scale (Y-BOCS)
排除标准
- •Receiving any treatment up to 6 weeks before the start of the trial
- •Diagnosis of another psychiatric disorder
研究者
相似试验
已完成
2 期
ondansetron in the treatment of obsessive-compulsive disorderObsessive- Cumpulsive Disorder.Obsessive-compulsive disorderIRCT201204271556N41Tehran University of Medical Sciences40
已完成
不适用
Feasibility of adjuvant treatment with S-1 and oxaliplatin in patients with resectable esophageal canceresophageal cancerNL-OMON47475Academisch Medisch Centrum40
已完成
2 期
Scoploamine in the treatment of major depressioMajor Depressive episode.Major Depressive episodeIRCT201201181556N31Tehran University of Medical Sciences40
招募中
2 期
Amantadin as adjuvant therapy in the treatment of moderate to severe OCDObsessive-compulsive disorderObsessive- Cumpulsive Disorder.IRCT201705191556N99Tehran University of Medical Sciences50
进行中（未招募）
不适用
The use of Oxytocin for the treatment of schizophreniaSchizophreniaEUCTR2012-004504-35-ITIRCCS CENTRO SAN GIOVANNI DI DIO FATEBENEFRATELLI